WELCOME

The Australasian Gastro-Intestinal Trials Group (AGITG) is the only research organisation in the Australasian region with a focus on gastro-intestinal cancers.

Widely known throughout Australasia as the premier meeting in the gastro-intestinal (GI) cancer space, the AGITG Annual Scientific Meeting provides a forum where, on behalf of GI cancer patients, the enigmatic nature of gastro-intestinal cancer is challenged.  The three day program and shared exchange of knowledge is designed to uncover the mysteries of the many cancers that are GI cancer and meet the challenges facing health professionals in the treatment for this group of cancers.

The meeting provides gastro-intestinal cancer clinicians, researchers and allied health specialists with the opportunity to present their research and discuss current challenges and innovations, as well as to hear from international and local leaders on the latest in research and treatments. The meeting also provides an opportunity for involvement of health professionals in the scientific activities of the AGITG.

The program structure includes keynote sessions featuring international guest speakers, plenary and symposia sessions, trials presentations, poster session, new concepts symposium and workshops.

We look forward to seeing you in Adelaide, 21-23 August 2019.

 

lorraine chantrill

Dr Lorraine Chantrill
AGITG Annual Scientific Meeting Convenor

Russell Conley

Mr Russell Conley
AGITG Chief Executive Officer

Testimonials

Dr Daniel Renouf
British Columbia Cancer Agency, Vancouver Centre

Dan Renouf's Headshot

Dr Daniel Renouf

Medical Oncologist

British Columbia Cancer Agency, Vancouver Centre

Canada

“The 2018 AGITG ASM was an absolutely fantastic meeting.  Very well organized, and excellent sessions with a very good mix of education as well as trial updates and future trial design discussions.   The organizing and administrative committee did an amazing job with the logistics and the venue, meals, and all aspects of the program.  I would highly recommend this meeting!”

Daniel Chang's Headshot

Daniel Chang, MD

Sue and Bob McCollum Professor

Department of Radiation Oncology

Stanford University

“I thought the AGITG Annual Scientific Meeting was a fantastic opportunity to share ideas on current and future directions of the state of our field.  It was great to meet so many esteemed colleagues from all over the world and hear about the many great advances.  A particular highlight for me was the chance to have meaningful and thoughtful discussions about clinical trials in development.  It was really a unique and valuable chance to give input at the formative stages and share our experiences that inform our current trial designs.  I have not seen this type of format at any other scientific meeting.  This entire meeting was a great experience, and I would encourage anyone with an interest in gastrointestinal malignancies to attend.”

Dr Matthew Burge
Royal Brisbane & Women’s Hospital

Matt Burge

Dr Matthew Burge

Medical Oncologist
Royal Brisbane & Women’s Hospital

Winner of the 2014 Best New Concept Award and recipient of the 2016 Innovation Grant for the MONARCC Study: A randomised Phase II study of panitumumab monotherapy versus panitumumab and 5 Fluorouracil as first line treatment for RAS and RAF wild type metastatic colorectal cancer (mCRC).

“I find the AGITG Annual Scientific Meeting to be an invaluable learning experience. Like many things, what you put in correlates with what you take away. My efforts to submit a new concept proposal were rewarded when it was selected for oral presentation at the New Concepts Symposium at the 2014 meeting. This led to invaluable feedback and ongoing support from the AGITG which has ultimately led to a completed protocol and a study opening to recruitment in March 2018. This is such an exciting outcome for my research career and I have the AGITG to thank for it. The invited faculty is always first class and this meeting provides ample opportunity to network with the faculty (from Australia and overseas) hence learn so much more than just what is delivered in lectures. I can thoroughly recommend attendance at the AGITG Annual Scientific Meeting.”

A/Prof George Hruby
Genesis Cancer Care, Sydney

George Hruby

A/Prof George Hruby

Radiation Oncologist
Genesis Cancer Care, Sydney

“The AGITG Annual Scientific Meeting is like a big, happy, empowering trans-national multi-disciplinary team meeting where state of the art management and current trials are tossed around by key craft groups. For Radiation Oncologists, the RO specific session is invaluable. There is generally an invited speaker who comments on our art during a contouring workshop which is always interactive and inclusive. Several RO contouring guidelines have been published directly consequent to these workshops.”

Prof Andrew Barbour
Princess Alexandra Hospital, Brisbane

Prof Andrew Barbour

Prof Andrew Barbour

Surgeon
Princess Alexandra Hospital, Brisbane

“The AGITG ASM is a multidisciplinary meeting focussed on the current and future management of GI cancer. It provides not only high quality educational material across the spectrum of GI cancer, but encourages the presentation of new clinical trial ideas. Through the New Concepts Symposium, clinical trial concepts are presented and refined for development into national or international studies. The meeting is suitable for trainees and senior clinicians as well as paramedical practitioners engaged in all aspects of GI cancer management.”

Dr Sharon Pattison
University of Otago and Southern District Health Board, Dunedin

Sharon Pattison

Dr Sharon Pattison

Medical Oncologist
University of Otago and Southern District Health Board, Dunedin

“I attended my first AGITG Annual Scientific Meeting as an advanced trainee newly starting a PhD. It was a great educational meeting that had instructive symposia with an interesting and approachable local and international faculty. Those features have been present at each AGITG ASM that I have subsequently attended, and I have found the ASM to be an invaluable forum for presentation of research, less formal discussion of research themes and ideas, and learning about the challenges involved in clinical trial design. The AGITG ASM environment supports collaboration and networking, and I would highly recommend the meeting to all trainees, researchers, investigators and clinicians who have an interest in gastro-intestinal cancers.”

Ms Anne Smith
Canterbury Regional Cancer and Haematology Service

Anne Smith

Ms Anne Smith

Clinical Trials Manager
Christchurch Oncology Research Unit
Canterbury Regional Cancer and Haematology Service

“Key to the AGITG philosophy is a desire to improve the health and quality of life of people with gastro-intestinal cancer by conducting high quality collaborative clinical trials. In developing and conducting these trials the AGITG has successfully encompassed specialists, nurses, research coordinators, scientists, allied health professionals and consumers.

The AGITG Annual Scientific Meeting provides an excellent forum for all these disciplines to come together to share knowledge and experiences and learn from a wide variety of invited international speakers. Incorporated in the meeting are sessions specifically targeting study coordinators and allied health professionals. Speakers and topics for interactive discussion are chosen to complement the annual theme of the meeting and address issues that may arise from a study coordinator perspective.

This is a valuable meeting and excellent opportunity to learn more about clinical trials, changes in medical practice and to exchange ideas and experiences with other study coordinators.”

Dr Katherine Geddes
St Vincent's Hospital, Melbourne

Katherine Geddes

Dr Katherine Geddes

Medical Oncologist & Oncology Research Fellow
St Vincent’s Hospital, Melbourne

Winner of the 2017 Best New Concept Award

“I find the AGITG Annual Scientific Meeting a great meeting to attend. It is a great opportunity to learn where GI cancer research and practice is heading with many opportunities to network and collaborate. I found the New Concepts process highly supportive, encouraging and a fantastic learning process – it has stimulated my research to a new level, for which I am grateful for the opportunity.”

Dr David Lau
Olivia Newton John Cancer Research Centre

David Lau

Dr David Lau

Clinical Research Fellow
Olivia Newton John Cancer Research Centre

Recipient of the 2018 Merck-AGITG Clinical Research Fellowship

“The AGITG Annual Scientific Meeting is a thoroughly enjoyable conference for all involved in GI cancer. The AGITG have a longstanding commitment to education and invite a high calibre of international and local speakers to deliver an informative program. As an early-career delegate, the conference provided me with a forum to present my research and meet likeminded clinicians, researchers and new collaborators.”

Prof Diana Sarfati
University of Otago, Wellington, New Zealand

Head Shot of Diana Sarfati

Prof Diana Sarfati

Head of Department, Department of Public Health

Professor, Director; Cancer and Chronic Conditions (C3) research group

University of Otago, Wellington, New Zealand

“It was a great pleasure to attend the 2018 AGITG meeting in Brisbane. The conference was vibrant and engaging, with an excellent array of speakers and session types. The programme encouraged collaboration and discussion, with excellent networking opportunities, as well as top notch content. As icing on the cake, the social programme was uniquely hilarious and unlike any other conference I’ve ever been to.”

Dr Wee Loon Ong – 2018 New Concept Award, Runner-Up
Olivia Newton John Cancer Research and Wellness Centre

Wee Loon On'gs Headshot

Dr Wee Loon Ong – 2018 New Concept Award, Runner-Up

Radiation Oncology Clinical Research Fellow,

Olivia Newton-John Cancer Research and Wellness Centre

“I find the AGITG Annual Scientific Meeting to be an educational meeting, with a good mix of speakers from all specialties. I am honoured to have the opportunity to present my ideas at the New Concept Symposium, which generated highly critical and constructive feedback. The AGITG ASM is definitely recommended to any trainees interested in GI cancer clinical trials.”

Carole Mott's Headshot

Ms Carole Mott – 2018 recipient NEWBIE Special Offer

Goulburn Valley Health – Clinical Trials

Shepparton, VIC

“I thoroughly enjoyed the AGITG conference. It was so informative and a great networking opportunity to meet with other study coordinators and clinicians. The AGITG group did an amazing job. I am already looking forward to next year.

Thank you so much for the opportunity to participate.”